ReShape Intragastric Balloon for the Treatment of Obesity

2014-07-24 14:10:45 | BioPortfolio


A prospective, non-randomized, open-label, multi-center study designed to implant up to twenty (20) CE-marked ReShape™ Balloons in twenty (20) patients with body mass index (BMI) 30-40] to assess the effectiveness of the device. The RIB devices will be used within their labeled indications and as per their instructions for use. Enrolled patients will be followed for seven months. The patient will be prescribed a controlled diet, exercise and counseling. One group of 20 patients will receive treatment as follows: Placement, inflate to 900 cc, remove at 180 days, follow-up 30 days post removal (endoscopic video capture of placement and removal required).

Study Design

Allocation: Non-Randomized, Control: Uncontrolled, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment




Intragastric Balloon


Casa di Cura Solatrix




ReShape Medical, Inc.

Results (where available)

View Results


Published on BioPortfolio: 2014-07-24T14:10:45-0400

Clinical Trials [951 Associated Clinical Trials listed on BioPortfolio]

Intragastric Balloon in Obese Adolescents With Comorbidities

The reason we are doing this research is to get information about the ORBERA™ Intragastric Balloon to learn if it is safe and if it works. We want to learn if older teenagers who are ove...

Endoscopic Intragastric Balloon Placement for Weight Loss in Liver Transplant Waitlist Candidates

The purpose of this study is to determine whether the ORBERA Intragastric Balloon is a safe and effective means for weight loss and improved metabolic disease in patients with cirrhosis re...

Monitoring Stomach Function With an Intragastric Balloon - a Pilot

In this pilot study the investigators test the hypothesis that gastric motility can be measured with an intragastric balloon.

Optimization and Follow-up of the Consecutive Use of Two Intragastric Balloons in the Treatment of Obesity

This is a cohort study with the objective of describing during a 12-month follow-up, weight loss in obese patients submitted to treatment using two consecutively air-filled IGB (Heliospher...

Adjustable Balloons for Weight Loss: A Higher Yield of Responders Compared With Non-Adjustable Balloons

Intragastric balloon degree of efficacy and duration of effect can be variable and unpredictable. The Spatz Adjustable intragastric balloon (AIGB) was developed to extend implantation to 1...

PubMed Articles [2902 Associated PubMed Articles listed on BioPortfolio]

Acute Pancreatitis: A Complication of Intragastric Balloon.

This study was carried out because intragastric balloon (IGB) is a widely used method to combat obesity, and acute pancreatitis complicating IGB is rare and yet to be understood.

Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-world Population.

The Orbera Intragastric Balloon (OIB) is a single fluid-filled intra-gastric balloon approved for induction of weight loss and treatment of obesity. However, little is known about the effectiveness an...

The safety and efficacy of the procedureless intragastric balloon.

Obesity is on a continuous rise worldwide, and with it, novel bariatric procedures have emerged. The introduction of gastric balloons has opened up a nonsurgical option for patients opting for it. How...

Laparoscopic management of a small bowel obstruction secondary to Elipse intragastric balloon migration: A case report.

The Elipse™ intragastric balloon (IGB) for weight loss is a swallowable capsule that is filled with 550mL of fluid and resides in the stomach for four months before being excreted from the gastroint...

Intragastric injection of botulinum toxin. A real alternative for obesity treatment? A systematic review.

Obesity is a prevalent disease in our environment, which comorbidities suppose a great challenge to public health. Intragastric injection of botulinum toxin has been used as treatment for obesity, bot...

Medical and Biotech [MESH] Definitions

An inflatable device implanted in the stomach as an adjunct to therapy of morbid obesity. Specific types include the silicone Garren-Edwards Gastric Bubble (GEGB), approved by the FDA in 1985, and the Ballobes Balloon.

The use of balloon CATHETERS to remove emboli by retraction of the balloon that is inflated behind the EMBOLUS.

A balloon-assisted enteroscopy utilizing a flexible endoscope with one overtube balloon control unit.

Widening of a stenosed HEART VALVE by the insertion of a balloon CATHETER into the valve and inflation of the balloon.

Counterpulsation in which a pumping unit synchronized with the patient's electrocardiogram rapidly fills a balloon in the aorta with helium or carbon dioxide in early diastole and evacuates the balloon at the onset of systole. As the balloon inflates, it raises aortic diastolic pressure, and as it deflates, it lowers aortic systolic pressure. The result is a decrease in left ventricular work and increased myocardial and peripheral perfusion.

More From BioPortfolio on "ReShape Intragastric Balloon for the Treatment of Obesity"

Quick Search


Relevant Topic

Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...

Searches Linking to this Trial